Obesity therapy: altering the energy intake-and-expenditure balance sheet

Obesity is associated with numerous health complications, which range from non-fatal debilitating conditions such as osteoarthritis, to life-threatening chronic diseases such as coronary heart disease, diabetes and certain cancers. The psychological consequences of obesity can range from lowered self-esteem to clinical depression. Despite the high prevalence of obesity and the many advances in our understanding of how it develops, current therapies have persistently failed to achieve long-term success. This review focuses on how fat mass can be reduced by altering the balance between energy intake and expenditure.

[1]  Rene Devos,et al.  Identification and expression cloning of a leptin receptor, OB-R , 1995, Cell.

[2]  S. O’Rahilly,et al.  Metabolism: Partial leptin deficiency and human adiposity , 2001, Nature.

[3]  G. P. Smith,et al.  Cholecystokinin decreases food intake in rats. , 1973, Journal of comparative and physiological psychology.

[4]  J. Flier,et al.  A Transgenic Model of Visceral Obesity and the Metabolic Syndrome , 2001, Science.

[5]  M. Mortrud,et al.  Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Emmanuel Mignot,et al.  The Sleep Disorder Canine Narcolepsy Is Caused by a Mutation in the Hypocretin (Orexin) Receptor 2 Gene , 1999, Cell.

[7]  S. O’Rahilly,et al.  The role of melanocortin signalling in the control of body weight: evidence from human and murine genetic models. , 2000, QJM : monthly journal of the Association of Physicians.

[8]  M. Caulfield.  Muscarinic receptors--characterization, coupling and function. , 1993, Pharmacology & therapeutics.

[9]  P. Puigserver,et al.  A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis , 1998, Cell.

[10]  A. Blomqvist,et al.  Y-receptor subtypes—how many more? , 1997, Trends in Neurosciences.

[11]  Guillaume Adelmant,et al.  Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1 , 2001, Nature.

[12]  S. O’Rahilly,et al.  Congenital leptin deficiency is associated with severe early-onset obesity in humans , 1997, Nature.

[13]  G. V. Dijk,et al.  Glucagon-like peptide-1 (7–36) amide: a central regulator of satiety and interoceptive stress , 1999, Neuropeptides.

[14]  P. J. Larsen,et al.  Hypothalamic CART is a new anorectic peptide regulated by leptin , 1998, Nature.

[15]  L. Tecott,et al.  Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene , 1998, Nature Medicine.

[16]  G. Yancopoulos,et al.  The ciliary neurotrophic factor and its receptor, CNTFRα , 2000 .

[17]  W. Vale,et al.  Modulation of urocortin-induced hypophagia and weight loss by corticotropin-releasing factor receptor 1 deficiency in mice. , 2000, Endocrinology.

[18]  B. Lowell,et al.  Mice lacking melanin-concentrating hormone are hypophagic and lean , 1998, Nature.

[19]  P. Hartig.  Molecular pharmacology of serotonin receptors. , 1994, EXS.

[20]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1995, Nature.

[21]  R. Steiner,et al.  Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice. , 1997, Endocrinology.

[22]  C. Lawrence,et al.  Alternative role for prolactin-releasing peptide in the regulation of food intake , 2000, Nature Neuroscience.

[23]  P S Kalra,et al.  Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. , 1984, Endocrinology.

[24]  W Li,et al.  Identification and characterization of a melanin-concentrating hormone receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[25]  R. Cone,et al.  A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. , 2000, Endocrinology.

[26]  V. Mootha,et al.  Mechanisms Controlling Mitochondrial Biogenesis and Respiration through the Thermogenic Coactivator PGC-1 , 1999, Cell.

[27]  B. Lowell,et al.  Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance. , 2001, The Journal of clinical investigation.

[28]  C. Langmead,et al.  Characterization of the binding of [(125)I]-human prolactin releasing peptide (PrRP) to GPR10, a novel G protein coupled receptor. , 2000, British journal of pharmacology.

[29]  A. Yamanaka,et al.  Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean , 2001, Nature.

[30]  K. Fujioka,et al.  Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study. , 1999, The American journal of clinical nutrition.

[31]  R. A. Norman,et al.  Association between uncoupling protein polymorphisms (UCP2-UCP3) and energy metabolism/obesity in Pima indians. , 1998, Human molecular genetics.

[32]  M. Reitman,et al.  Lipoatrophy Revisited , 2000, Trends in Endocrinology & Metabolism.

[33]  B. Lowell,et al.  In Vivo Effects of Uncoupling Protein-3 Gene Disruption on Mitochondrial Energy Metabolism* , 2001, The Journal of Biological Chemistry.

[34]  A. Joyner,et al.  Glucose intolerance but normal satiety in mice with a null mutation in the glucagon–like peptide 1 receptor gene , 1996, Nature Medicine.

[35]  R. Cone,et al.  The central melanocortin system can directly regulate serum insulin levels. , 2000, Endocrinology.

[36]  T. Pedrazzini,et al.  Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor , 1998, Nature Medicine.

[37]  Bruce M. Spiegelman,et al.  Towards a molecular understanding of adaptive thermogenesis , 2000, Nature.

[38]  T. Kirkham,et al.  Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors , 1999, Psychopharmacology.

[39]  R. Palmiter,et al.  Attenuation of the Obesity Syndrome of ob/ob Mice by the Loss of Neuropeptide Y , 1996, Science.

[40]  J. Manzanares,et al.  Identification of Endocannabinoids and Cannabinoid CB1 Receptor mRNA in the Pituitary Gland , 1999, Neuroendocrinology.

[41]  Steven L. Cohen,et al.  Weight-reducing effects of the plasma protein encoded by the obese gene. , 1995, Science.

[42]  S. O’Rahilly,et al.  Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. , 2000, The Journal of clinical investigation.

[43]  E. Berry,et al.  Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice. , 2000, European journal of pharmacology.

[44]  Christopher P. Austin,et al.  Identification and characterization of a second melanin-concentrating hormone receptor, MCH-2R , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[45]  S. Carr,et al.  Orexins and Orexin Receptors: A Family of Hypothalamic Neuropeptides and G Protein-Coupled Receptors that Regulate Feeding Behavior , 1998, Cell.

[46]  A. Strosberg,et al.  A leptin missense mutation associated with hypogonadism and morbid obesity , 1998, Nature Genetics.

[47]  E. Gibson,et al.  Appetite suppression by commonly used drugs depends on 5-HT receptors but not on 5-HT availability. , 1997, TIPS - Trends in Pharmacological Sciences.

[48]  G. Bray,et al.  Afferent signals regulating food intake , 2000, Proceedings of the Nutrition Society.

[49]  Jon T. Willie,et al.  Narcolepsy in orexin Knockout Mice Molecular Genetics of Sleep Regulation , 1999, Cell.

[50]  J. Sorkin,et al.  Effects of GH and/or sex steroid administration on abdominal subcutaneous and visceral fat in healthy aged women and men. , 2001, The Journal of clinical endocrinology and metabolism.

[51]  B. Cannon,et al.  Only UCP1 can mediate adaptive nonshivering thermogenesis in the cold , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[52]  R. Palmiter,et al.  Role of the Y5 neuropeptide Y receptor in feeding and obesity , 1998, Nature Medicine.

[53]  J. Bue-Valleskey,et al.  The role of neuropeptide Y in the antiobesity action of the obese gene product , 1995, Nature.

[54]  K. Chada,et al.  In vivo modulation of Hmgic reduces obesity , 2000, Nature Genetics.

[55]  Susan E. Murray,et al.  Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2 , 2000, Nature Genetics.

[56]  B. Spiegelman,et al.  Adipose tissue reduction in mice lacking the translational inhibitor 4E-BP1 , 2001, Nature Medicine.

[57]  A. Itai,et al.  Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes. , 2001, The Journal of clinical investigation.

[58]  C. Wahlestedt,et al.  Specific inhibition of endogenous neuropeptide Y synthesis in arcuate nucleus by antisense oligonucleotides suppresses feeding behavior and insulin secretion. , 1994, Brain research. Molecular brain research.

[59]  G. Koob,et al.  Appetite-Suppressing Effects of Urocortin, a CRF-Related Neuropeptide , 1996, Science.

[60]  S. Carr,et al.  Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. , 1998, Cell.

[61]  J. Flier,et al.  Chewing the Fat--ACC and Energy Balance , 2001, Science.

[62]  G. Yancopoulos,et al.  Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat, without cachexia or rebound weight gain, even in leptin-resistant obesity , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[63]  Rick B. Vega,et al.  The Coactivator PGC-1 Cooperates with Peroxisome Proliferator-Activated Receptor α in Transcriptional Control of Nuclear Genes Encoding Mitochondrial Fatty Acid Oxidation Enzymes , 2000, Molecular and Cellular Biology.

[64]  J. Vaughan,et al.  The melanin‐concentrating hormone system of the rat brain: An immuno‐ and hybridization histochemical characterization , 1992, The Journal of comparative neurology.

[65]  C. Niederau,et al.  Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice. , 1987, Gut.

[66]  Christophe Fleury,et al.  Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia , 1997, Nature Genetics.

[67]  G. Bray,et al.  Effects of corticotropin-releasing factor on food intake and brown adipose tissue thermogenesis in rats. , 1988, The American journal of physiology.

[68]  M. Nakazato,et al.  A role for ghrelin in the central regulation of feeding , 2001, Nature.

[69]  Yumiko Saito,et al.  Molecular characterization of the melanin-concentrating-hormone receptor , 1999, Nature.

[70]  Martin D. Brand,et al.  Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean , 2000, Nature.

[71]  S. Whitebread,et al.  A receptor subtype involved in neuropeptide-Y-induced food intake , 1996, Nature.

[72]  Patrick R. Griffin,et al.  A Receptor in Pituitary and Hypothalamus That Functions in Growth Hormone Release , 1996, Science.

[73]  Claude Bouchard,et al.  Handbook of obesity , 1997 .

[74]  G. Schwartz,et al.  Intracerebroventricular CART peptide reduces food intake and alters motor behavior at a hindbrain site. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[75]  Motonao Nakamura,et al.  Obesity and mild hyperinsulinemia found in neuropeptide Y-Y1 receptor-deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[76]  C. Deng,et al.  Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[77]  R. Palmiter,et al.  Leptin-regulated endocannabinoids are involved in maintaining food intake , 2001, Nature.

[78]  R. Scarpulla.  Nuclear Control of Respiratory Chain Expression in Mammalian Cells , 1997, Journal of bioenergetics and biomembranes.

[79]  C. Langmead,et al.  Characterization of the binding of [125I]‐human prolactin releasing peptide (PrRP) to GPR10, a novel G protein coupled receptor , 2000 .

[80]  M. Mortrud,et al.  Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. , 1994, Molecular endocrinology.

[81]  L. Parada,et al.  BDNF regulates eating behavior and locomotor activity in mice , 2000, The EMBO journal.

[82]  Paul E. Sawchenko,et al.  Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress , 2000, Nature Genetics.

[83]  J. Hebebrand,et al.  Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans. , 1999, The Journal of clinical endocrinology and metabolism.

[84]  Robert V Farese,et al.  Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat , 2000, Nature Genetics.

[85]  K. Clément,et al.  Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. , 2000, The Journal of clinical investigation.

[86]  B. Lowell,et al.  UCP3: an uncoupling protein homologue expressed preferentially and abundantly in skeletal muscle and brown adipose tissue. , 1997, Biochemical and biophysical research communications.

[87]  B. Lowell,et al.  The Human Uncoupling Protein-3 Gene , 1997, The Journal of Biological Chemistry.

[88]  S. Watson,et al.  Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. , 1993, The Journal of biological chemistry.

[89]  R. Cone,et al.  The Central Melanocortin System and Energy Homeostasis , 1999, Trends in Endocrinology & Metabolism.

[90]  Satoshi Tanaka,et al.  PPARγ Mediates High-Fat Diet–Induced Adipocyte Hypertrophy and Insulin Resistance , 1999 .

[91]  E. Arenas,et al.  Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor , 1999, Nature Medicine.

[92]  S. Gammeltoft,et al.  A role for melanin-concentrating hormone in the central regulation of feeding behaviour , 1996, Nature.

[93]  C. Mantzoros,et al.  Role of leptin in the neuroendocrine response to fasting , 1996, Nature.

[94]  Y. Chagnon,et al.  Linkage between markers in the vicinity of the uncoupling protein 2 gene and resting metabolic rate in humans. , 1997, Human molecular genetics.

[95]  S. O’Rahilly,et al.  Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension , 1999, Nature.

[96]  Roy G. Smith,et al.  Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. , 1997, Brain research. Molecular brain research.

[97]  Martin M. Matzuk,et al.  Continuous Fatty Acid Oxidation and Reduced Fat Storage in Mice Lacking Acetyl-CoA Carboxylase 2 , 2001, Science.

[98]  Yun-Fei Chen,et al.  Absence of Cocaine- and Amphetamine-Regulated Transcript Results in Obesity in Mice Fed a High Caloric Diet. , 2001, Endocrinology.

[99]  G. Barsh,et al.  Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. , 1997, Science.

[100]  K. Fujioka,et al.  Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. , 1999, JAMA.

[101]  R. Scarpulla,et al.  Nuclear respiratory factors 1 and 2 utilize similar glutamine-containing clusters of hydrophobic residues to activate transcription , 1996, Molecular and cellular biology.

[102]  V. Mootha,et al.  Energy Metabolism in Uncoupling Protein 3 Gene Knockout Mice* , 2000, The Journal of Biological Chemistry.

[103]  M. Tschöp,et al.  Ghrelin induces adiposity in rodents , 2000, Nature.

[104]  A. Prentice,et al.  Effects of recombinant leptin therapy in a child with congenital leptin deficiency. , 1999, The New England journal of medicine.

[105]  P. Carlsson,et al.  FOXC2 Is a Winged Helix Gene that Counteracts Obesity, Hypertriglyceridemia, and Diet-Induced Insulin Resistance , 2001, Cell.

[106]  R. Guerciolini.  Mode of action of orlistat. , 1997, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[107]  E. Danforth.  Failure of adipocyte differentiation causes type II diabetes mellitus? , 2000, Nature Genetics.

[108]  M. Olive,et al.  Life without white fat: a transgenic mouse. , 1998, Genes & development.

[109]  R. Scarpulla,et al.  Activation of the human mitochondrial transcription factor A gene by nuclear respiratory factors: a potential regulatory link between nuclear and mitochondrial gene expression in organelle biogenesis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[110]  R. Palmiter,et al.  Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y , 1996, Nature.

[111]  C. Weyer,et al.  Development of beta 3-adrenoceptor agonists for the treatment of obesity and diabetes--an update. , 1999, Diabetes & metabolism.

[112]  R. Young,et al.  Cholecystokinin elicits Satiety in Rats with Open Gastric Fistulas , 1973, Nature.

[113]  S. Leibowitz,et al.  Neuropeptide Y chronically injected into the hypothalamus: A powerful neurochemical inducer of hyperphagia and obesity , 1986, Peptides.

[114]  S. O’Rahilly,et al.  Regulation of adipose cell number in man. , 1997, Clinical science.

[115]  D. Gorenstein,et al.  Absence of perilipin results in leanness and reverses obesity in Leprdb/db mice , 2000, Nature Genetics.

[116]  R. Cone,et al.  Altered expression of agouti-related protein and its colocalization with neuropeptide Y in the arcuate nucleus of the hypothalamus during lactation. , 1999, Endocrinology.

[117]  Christopher P. Austin,et al.  Identification of receptors for neuromedin U and its role in feeding , 2000, Nature.

[118]  Yue Feng,et al.  Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass , 2000, Nature Genetics.

[119]  X. Bertagna.  Proopiomelanocortin-derived peptides. , 1994, Endocrinology and metabolism clinics of North America.

[120]  D. Jacobowitz,et al.  Immunohistochemical localization of a melanin concentrating hormone-like peptide in the rat brain , 1985, Brain Research Bulletin.

[121]  R. Cone,et al.  Targeted Disruption of the Melanocortin-4 Receptor Results in Obesity in Mice , 1997, Cell.

[122]  S. Leibowitz,et al.  Neuropeptide Y: stimulation of feeding and drinking by injection into the paraventricular nucleus. , 1984, Life sciences.

[123]  R. Cone,et al.  A Unique Metalolic Sysdrone Causes Obesity in the Melanocortin-3 Receptor-Deficient Mouse. , 2000, Endocrinology.

[124]  P. Puigserver,et al.  Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional coactivator PGC-1 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[125]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[126]  N. Ling,et al.  Injection of anti-neuropeptide Y γ-globulin into the hypothalamic paraventricular nucleus decreases food intake in rats , 1993, Brain Research.

[127]  M. Brand,et al.  The Physiological Significance of Mitochondrial Proton Leak in Animal Cells and Tissues , 1997, Bioscience reports.

[128]  J. Chambers,et al.  Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1 , 1999, Nature.

[129]  Young-Bum Kim,et al.  Uncoupling Protein-2 Negatively Regulates Insulin Secretion and Is a Major Link between Obesity, β Cell Dysfunction, and Type 2 Diabetes , 2001, Cell.

[130]  S. Watson,et al.  Molecular cloning of a novel melanocortin receptor. , 1993, The Journal of biological chemistry.

[131]  B. Kennedy,et al.  Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. , 1999, Science.

[132]  O. Boss,et al.  Uncoupling protein‐3: a new member of the mitochondrial carrier family with tissue‐specific expression , 1997, FEBS letters.

[133]  Young-Bum Kim,et al.  Increased Energy Expenditure, Decreased Adiposity, and Tissue-Specific Insulin Sensitivity in Protein-Tyrosine Phosphatase 1B-Deficient Mice , 2000, Molecular and Cellular Biology.

[134]  R. Mechoulam,et al.  Towards cannabinoid drugs--revisited. , 1998, Progress in medicinal chemistry.

[135]  R. Evans,et al.  Improved insulin-sensitivity in mice heterozygous for PPAR-γ deficiency , 2000 .

[136]  M. Nakazato,et al.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach , 1999, Nature.

[137]  R. Considine,et al.  Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance , 1996, The Lancet.

[138]  H. Hsiung,et al.  Absence of cocaine- and amphetamine-regulated transcript results in obesity in mice fed a high caloric diet. , 2001, Endocrinology.

[139]  J. Flier,et al.  Cell biology. Chewing the fat--ACC and energy balance. , 2001, Science.